Literature DB >> 26843200

A promising carbon-11-labeled sphingosine-1-phosphate receptor 1-specific PET tracer for imaging vascular injury.

Hongjun Jin1, Hao Yang1, Hui Liu1, Yunxiao Zhang1, Xiang Zhang1, Adam J Rosenberg1, Yongjian Liu1, Suzanne E Lapi1, Zhude Tu2.   

Abstract

BACKGROUND: Sphingosine-1-phosphate receptor 1 (S1PR1) is highly expressed in vascular smooth muscle cells from intimal lesions. PET imaging using S1PR1 as a biomarker would increase our understanding of its role in vascular pathologies including in-stent restenosis.
METHODS: The S1PR1 compound TZ3321 was synthesized for in vitro characterization and labeled with Carbon-11 for in vivo studies. The biodistribution of [11C]TZ3321 was evaluated in normal mice; microPET and immunohistochemistry (IHC) studies were performed using a murine femoral artery wire-injury model of restenosis.
RESULTS: The high potency of TZ3321 for S1PR1 (IC 50 = 2.13 ± 1.63 nM), and high selectivity (>1000 nM) for S1PR1 over S1PR2 and S1PR3 were confirmed. Biodistribution data revealed prolonged retention of [11C]TZ3321 in S1PR1-enriched tissues. MicroPET imaging of [11C]TZ3321 showed higher uptake in the wire-injured arteries of ApoE-/- mice than in injured arteries of wild-type mice (SUV 0.40 ± 0.06 vs 0.28 ± 0.04, n = 6, P < .001); FDG-PET showed no difference (SUV 0.98 ± 0.04 vs 0.94 ± 0.01, n = 6, P > .05). Post-PET autoradiography showed >4-fold higher [11C]TZ3321 retention in the injured artery of ApoE-/- mice than in wild-type mice. Subsequent IHC staining confirmed higher expression of S1PR1 in the neointima of the injured artery of ApoE-/- mice than in wild-type mice.
CONCLUSIONS: This preliminary study supports the potential use of PET for quantification of the S1PR1 expression as a biomarker of neointimal hyperplasia.

Entities:  

Keywords:  MicroPET imaging; atherosclerosis; biodistribution; diagnostic and prognostic application; inflammation

Mesh:

Substances:

Year:  2016        PMID: 26843200     DOI: 10.1007/s12350-015-0391-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  22 in total

1.  Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

Authors:  Suzanne Mandala; Richard Hajdu; James Bergstrom; Elizabeth Quackenbush; Jenny Xie; James Milligan; Rosemary Thornton; Gan-Ju Shei; Deborah Card; CarolAnn Keohane; Mark Rosenbach; Jeffrey Hale; Christopher L Lynch; Kathleen Rupprecht; William Parsons; Hugh Rosen
Journal:  Science       Date:  2002-03-28       Impact factor: 47.728

2.  Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient mice.

Authors:  E D Reis; M Roque; H Dansky; J T Fallon; J J Badimon; C Cordon-Cardo; S J Shiff; E A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 3.  Vascular imaging with positron emission tomography.

Authors:  F Joshi; D Rosenbaum; S Bordes; J H F Rudd
Journal:  J Intern Med       Date:  2011-05-18       Impact factor: 8.989

Review 4.  The pathobiology of the vessel wall: implications for imaging.

Authors:  Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

5.  A practical process for the preparation of [(32)P]S1P and binding assay for S1P receptor ligands.

Authors:  Adam J Rosenberg; Hui Liu; Zhude Tu
Journal:  Appl Radiat Isot       Date:  2015-04-17       Impact factor: 1.513

6.  Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial).

Authors:  S J Boccuzzi; W S Weintraub; A S Kosinski; J B Roehm; J L Klein
Journal:  Am J Cardiol       Date:  1998-03-01       Impact factor: 2.778

7.  Cystatin C associates with the prediction of in-stent restenosis among patients receiving stent implantation: results of the 1-year follow-up.

Authors:  Chunyu Zhao; Lanshu Yang; Lili Mao; Lihua Zhong; Xueqi Li; Shipeng Wei
Journal:  Coron Artery Dis       Date:  2013-08       Impact factor: 1.439

8.  Fine-tuning S1P therapeutics.

Authors:  Hideru Obinata; Timothy Hla
Journal:  Chem Biol       Date:  2012-09-21

Review 9.  Inflammation as a marker for the prediction of internal carotid artery restenosis following eversion endarterectomy--evidence from clinical studies.

Authors:  Slobodan Tanaskovic; Esma R Isenovic; Djordje Radak
Journal:  Angiology       Date:  2011-08-25       Impact factor: 3.619

10.  A model of primary atherosclerosis and post-angioplasty restenosis in mice.

Authors:  Jeremy E Leidenfrost; M Faisal Khan; Kenneth P Boc; Brian R Villa; Emily T Collins; William C Parks; Dana R Abendschein; Eric T Choi
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

View more
  17 in total

1.  Specificity vs versatility: A fine balance for novel targeted molecular imaging radiotracers.

Authors:  James T Thackeray; Frank M Bengel
Journal:  J Nucl Cardiol       Date:  2016-02-10       Impact factor: 5.952

2.  Syntheses and in vitro biological evaluation of S1PR1 ligands and PET studies of four F-18 labeled radiotracers in the brain of nonhuman primates.

Authors:  Zonghua Luo; Junbin Han; Hui Liu; Adam J Rosenberg; Delphine L Chen; Robert J Gropler; Joel S Perlmutter; Zhude Tu
Journal:  Org Biomol Chem       Date:  2018-12-05       Impact factor: 3.876

3.  Upregulated Sphingosine 1-Phosphate Receptor 1 Expression in Human and Murine Atherosclerotic Plaques.

Authors:  Hui Liu; Hongjun Jin; Junbin Han; Xuyi Yue; Hao Yang; Mohamed A Zayed; Robert J Gropler; Zhude Tu
Journal:  Mol Imaging Biol       Date:  2018-06       Impact factor: 3.488

Review 4.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-11-08       Impact factor: 5.952

5.  Automated production of a sphingosine-1 phosphate receptor 1 (S1P1) PET radiopharmaceutical [11C]CS1P1 for human use.

Authors:  Zonghua Luo; Jiwei Gu; Robert C Dennett; Gregory G Gaehle; Joel S Perlmutter; Delphine L Chen; Tammie L S Benzinger; Zhude Tu
Journal:  Appl Radiat Isot       Date:  2019-06-20       Impact factor: 1.513

6.  Acute Rodent Tolerability, Toxicity, and Radiation Dosimetry Estimates of the S1P1-Specific Radioligand [11C]CS1P1.

Authors:  Hui Liu; Richard Laforest; Jiwei Gu; Zonghua Luo; Lynne A Jones; Robert J Gropler; Tammie L S Benzinger; Zhude Tu
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

7.  PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis.

Authors:  Hui Liu; Hongjun Jin; Xuyi Yue; Zonghua Luo; Chunling Liu; Adam J Rosenberg; Zhude Tu
Journal:  Mol Imaging Biol       Date:  2016-10       Impact factor: 3.488

8.  Syntheses and in vitro evaluation of new S1PR1 compounds and initial evaluation of a lead F-18 radiotracer in rodents.

Authors:  Zonghua Luo; Adam J Rosenberg; Hui Liu; Junbin Han; Zhude Tu
Journal:  Eur J Med Chem       Date:  2018-03-14       Impact factor: 6.514

9.  Design, Synthesis, and In Vitro and In Vivo Evaluation of an (18)F-Labeled Sphingosine 1-Phosphate Receptor 1 (S1P1) PET Tracer.

Authors:  Adam J Rosenberg; Hui Liu; Hongjun Jin; Xuyi Yue; Sean Riley; Steven J Brown; Zhude Tu
Journal:  J Med Chem       Date:  2016-06-22       Impact factor: 7.446

10.  Synthesis and characterization of [125I]TZ6544, a promising radioligand for investigating sphingosine-1-phosphate receptor 2.

Authors:  Zonghua Luo; Qianwa Liang; Hui Liu; Joshi Sumit; Hao Jiang; Robyn S Klein; Zhude Tu
Journal:  Nucl Med Biol       Date:  2020-07-27       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.